Utilizing Technology-Enabled Intervention to Improve Blood Glucose Self-Management Outcome in Type 2 Diabetic Patients Initiated on Insulin Therapy: A Retrospective Real-World Study
Background. The aim of this study was to assess the benefits of a mobile-enabled app through Lilly Connected Care Program (LCCP) in achieving blood glucose control and adhering to self-monitoring of blood glucose in patients with type 2 diabetes mellitus (T2DM). Methods. This retrospective study inc...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2020/7249782 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832560136759017472 |
|---|---|
| author | Jian Lin Xia Li Shan Jiang Xiao Ma Yuxin Yang Zhiguang Zhou |
| author_facet | Jian Lin Xia Li Shan Jiang Xiao Ma Yuxin Yang Zhiguang Zhou |
| author_sort | Jian Lin |
| collection | DOAJ |
| description | Background. The aim of this study was to assess the benefits of a mobile-enabled app through Lilly Connected Care Program (LCCP) in achieving blood glucose control and adhering to self-monitoring of blood glucose in patients with type 2 diabetes mellitus (T2DM). Methods. This retrospective study included T2DM patients who were initiated on insulin therapy (mostly premixed insulin) after failure to respond to oral antidiabetic drugs. Patients were provided with glucometers enabled with synchronous data transmission to healthcare providers and family members. The primary objective was to assess the benefits of LCCP based on changes in fasting blood glucose (FBG) and postprandial glucose (PPG) levels from baseline to 12 weeks. Paired t-test was used to assess the change in blood glucose (BG) from baseline to week 12. Results. In total, 14,085 T2DM patients were recruited. Compared with baseline, significant reductions in FBG and PPG were evident at week 12 (FBG: -0.39 mmol/L; PPG: −0.79 mmol/L; both P<0.001). Furthermore, at week 12, the proportion of patients attaining a target glucose level of FBG <7.0 mmol/L and PPG <10.0 mmol/L was 25.37% and 59.68%, respectively, with a statistically significant increase compared with that at baseline (6.74% and 45.59%, respectively, both P<0.001). The frequent monitoring of patients could gain a higher target achievement of FBG (28.1% vs 24.2%) and PPG (64.4% vs 55.1%) than the occasional monitoring patients. Additionally, the incidence of hypoglycemia gradually decreased and was significantly lower than the baseline level. Conclusions. In T2DM patients with poor glycemic control, the application of mobile enabled intervention (LCCP) along with insulin significantly reduced the hypoglycemia while improving glycemic control during period of naïve initiating insulin therapy. Additionally, the high frequency of BG self-monitoring was associated with better glycemic control. |
| format | Article |
| id | doaj-art-bc719a650e8e4bd89f0d0f1bdf442f81 |
| institution | Kabale University |
| issn | 1687-8337 1687-8345 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Endocrinology |
| spelling | doaj-art-bc719a650e8e4bd89f0d0f1bdf442f812025-02-03T01:28:25ZengWileyInternational Journal of Endocrinology1687-83371687-83452020-01-01202010.1155/2020/72497827249782Utilizing Technology-Enabled Intervention to Improve Blood Glucose Self-Management Outcome in Type 2 Diabetic Patients Initiated on Insulin Therapy: A Retrospective Real-World StudyJian Lin0Xia Li1Shan Jiang2Xiao Ma3Yuxin Yang4Zhiguang Zhou5National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, ChinaNational Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, ChinaLilly (Shanghai) Management Co., Ltd, No. 288 Shimen No. 1 Road, Jingan District, Shanghai 200041, ChinaLilly Suzhou Pharmaceutical Co., Ltd, No. 288 Shimen No. 1 Road, Jingan District, Shanghai 200041, ChinaLilly Suzhou Pharmaceutical Co., Ltd, No. 288 Shimen No. 1 Road, Jingan District, Shanghai 200041, ChinaNational Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, ChinaBackground. The aim of this study was to assess the benefits of a mobile-enabled app through Lilly Connected Care Program (LCCP) in achieving blood glucose control and adhering to self-monitoring of blood glucose in patients with type 2 diabetes mellitus (T2DM). Methods. This retrospective study included T2DM patients who were initiated on insulin therapy (mostly premixed insulin) after failure to respond to oral antidiabetic drugs. Patients were provided with glucometers enabled with synchronous data transmission to healthcare providers and family members. The primary objective was to assess the benefits of LCCP based on changes in fasting blood glucose (FBG) and postprandial glucose (PPG) levels from baseline to 12 weeks. Paired t-test was used to assess the change in blood glucose (BG) from baseline to week 12. Results. In total, 14,085 T2DM patients were recruited. Compared with baseline, significant reductions in FBG and PPG were evident at week 12 (FBG: -0.39 mmol/L; PPG: −0.79 mmol/L; both P<0.001). Furthermore, at week 12, the proportion of patients attaining a target glucose level of FBG <7.0 mmol/L and PPG <10.0 mmol/L was 25.37% and 59.68%, respectively, with a statistically significant increase compared with that at baseline (6.74% and 45.59%, respectively, both P<0.001). The frequent monitoring of patients could gain a higher target achievement of FBG (28.1% vs 24.2%) and PPG (64.4% vs 55.1%) than the occasional monitoring patients. Additionally, the incidence of hypoglycemia gradually decreased and was significantly lower than the baseline level. Conclusions. In T2DM patients with poor glycemic control, the application of mobile enabled intervention (LCCP) along with insulin significantly reduced the hypoglycemia while improving glycemic control during period of naïve initiating insulin therapy. Additionally, the high frequency of BG self-monitoring was associated with better glycemic control.http://dx.doi.org/10.1155/2020/7249782 |
| spellingShingle | Jian Lin Xia Li Shan Jiang Xiao Ma Yuxin Yang Zhiguang Zhou Utilizing Technology-Enabled Intervention to Improve Blood Glucose Self-Management Outcome in Type 2 Diabetic Patients Initiated on Insulin Therapy: A Retrospective Real-World Study International Journal of Endocrinology |
| title | Utilizing Technology-Enabled Intervention to Improve Blood Glucose Self-Management Outcome in Type 2 Diabetic Patients Initiated on Insulin Therapy: A Retrospective Real-World Study |
| title_full | Utilizing Technology-Enabled Intervention to Improve Blood Glucose Self-Management Outcome in Type 2 Diabetic Patients Initiated on Insulin Therapy: A Retrospective Real-World Study |
| title_fullStr | Utilizing Technology-Enabled Intervention to Improve Blood Glucose Self-Management Outcome in Type 2 Diabetic Patients Initiated on Insulin Therapy: A Retrospective Real-World Study |
| title_full_unstemmed | Utilizing Technology-Enabled Intervention to Improve Blood Glucose Self-Management Outcome in Type 2 Diabetic Patients Initiated on Insulin Therapy: A Retrospective Real-World Study |
| title_short | Utilizing Technology-Enabled Intervention to Improve Blood Glucose Self-Management Outcome in Type 2 Diabetic Patients Initiated on Insulin Therapy: A Retrospective Real-World Study |
| title_sort | utilizing technology enabled intervention to improve blood glucose self management outcome in type 2 diabetic patients initiated on insulin therapy a retrospective real world study |
| url | http://dx.doi.org/10.1155/2020/7249782 |
| work_keys_str_mv | AT jianlin utilizingtechnologyenabledinterventiontoimprovebloodglucoseselfmanagementoutcomeintype2diabeticpatientsinitiatedoninsulintherapyaretrospectiverealworldstudy AT xiali utilizingtechnologyenabledinterventiontoimprovebloodglucoseselfmanagementoutcomeintype2diabeticpatientsinitiatedoninsulintherapyaretrospectiverealworldstudy AT shanjiang utilizingtechnologyenabledinterventiontoimprovebloodglucoseselfmanagementoutcomeintype2diabeticpatientsinitiatedoninsulintherapyaretrospectiverealworldstudy AT xiaoma utilizingtechnologyenabledinterventiontoimprovebloodglucoseselfmanagementoutcomeintype2diabeticpatientsinitiatedoninsulintherapyaretrospectiverealworldstudy AT yuxinyang utilizingtechnologyenabledinterventiontoimprovebloodglucoseselfmanagementoutcomeintype2diabeticpatientsinitiatedoninsulintherapyaretrospectiverealworldstudy AT zhiguangzhou utilizingtechnologyenabledinterventiontoimprovebloodglucoseselfmanagementoutcomeintype2diabeticpatientsinitiatedoninsulintherapyaretrospectiverealworldstudy |